• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic expands Samsung deal into neuromod

Medtronic expands Samsung deal into neuromod

December 11, 2015 By Fink Densford

Medtronic, SamsungMedtronic (NYSE:MDT) said it expanded its strategic partnership with Samsung Electronics (LON:BC94) into the neuromodulation arena, looking to treat chronic pain, movement disorders, incontinence and other conditions.

The announcement was made today at the North American Neuromodulation Soceity’s scientific session in Las Vegas.

The combination will position Samsung to develop tools on Google‘s (NSDQ:GOOG) Android tablet and smartphone platform that can communicate with Medtronic’s neuromodulation systems.

“Medtronic is committed to solving healthcare challenges, and through this alliance we intend to create efficiencies by developing digital solutions that connect patients and healthcare providers in real time. Medtronic has a track record of developing meaningful patient innovations, and this collaboration is the first step to providing more personalized patient care and arming patients and physicians with the best consumer-relevant technologies,” Medtronic neuromod prez Tom Tefft said in prepared remarks.

The pairing will allow Medtronic to deliver real-time health neuromodulation data to physicians and patients for improved management of care.

“Samsung is applying its deep understanding of how people use technology to bring new innovations to healthcare. These future solutions will help better manage the health of patients by providing them with advanced, easy-to-use tools that securely deliver real-time data to their physicians,” Samsung Electronics America chief medical officer Dave Rhew said in a prepared statement.

Fridley, Minn.-based Medtronic said it is developing a ‘range of future solutions’ in the neuromod sector, and the partnership aims to improve the transmission and access to data from such devices to allow for more informed, data-driven treatment decisions.

In June, Medtronic announced a similar partnership with Samsung to develop technology for diabetes management, with Samsung managing the Android-side development.

Samsung will help Medtronic develop an app for Android devices that will be compatible with its MiniMed Connect as the first project of a new partnership with the Korean electronics maker.

The deal is slated to focus on developing a range of products for people with diabetes, from remote viewing of data to fully integrated mobile and wearable devices that operate with diabetes management systems, Medtronic said.

Filed Under: Business/Financial News, Digital Health, Neurological Tagged With: Medtronic, Samsung Electronics Co. Ltd.

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy